$7.54 6.3%
KTRA Stock Price vs. AI Score
Data gathered: November 8

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Kintara Therapeutics

Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients.


Kintara Therapeutics
Price $7.54
Target Price Sign up
Volume 3,550,000
Market Cap $12M
Year Range $0.22 - $11.44
Dividend Yield 0%
Analyst Rating 0% buy
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '2401.5M-1.5M-2M-2.1M-0.045
Q4 '230910,000-910,000-1M-1M-0.236
Q3 '2301.1M-1.1M-3M-2.9M-1.830
Q2 '2304.5M-4.5M-3.3M-3.3M-1.950
Q1 '2301.3M-1.3M-3.3M-3.3M-1.940

Insider Transactions View All

Hoffman Robert E. filed to buy 55,000 shares at $0.5.
February 17 '22

What is the Market Cap of Kintara Therapeutics?

The Market Cap of Kintara Therapeutics is $12M.

What is the current stock price of Kintara Therapeutics?

Currently, the price of one share of Kintara Therapeutics stock is $7.54.

How can I analyze the KTRA stock price chart for investment decisions?

The KTRA stock price chart above provides a comprehensive visual representation of Kintara Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Kintara Therapeutics shares. Our platform offers an up-to-date KTRA stock price chart, along with technical data analysis and alternative data insights.

Does KTRA offer dividends to its shareholders?

As of our latest update, Kintara Therapeutics (KTRA) does not offer dividends to its shareholders. Investors interested in Kintara Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Kintara Therapeutics?

Some of the similar stocks of Kintara Therapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.